ahei full note

Acute Haemorrhagic Edema of Infancy – Notes for USMLE

Leave a reply
Paediatric Dermatology

Acute Haemorrhagic Edema of Infancy

The alarming rash that almost always gets better on its own — a deep dive for parents, students, and curious clinicians.

Medical Blog  ·  Dermatology  ·  Immunology  ·  Paediatrics

In this article

  1. When the rash looks worse than it is
  2. Who gets it — and when
  3. What is happening inside the skin
  4. The diagnostic triad
  5. Telling it apart from HSP
  6. How doctors confirm the diagnosis
  7. Management — less is more
  8. Prognosis and follow-up
  9. References

“A toddler in your clinic has enormous, coin-shaped bruise-like patches spreading across her cheeks and limbs. Her parents are terrified. But she is smiling, playing, and completely unconcerned. What is going on?”

When the rash looks worse than it is

Acute Haemorrhagic Edema of Infancy (AHEI) — also written as AHEi, and known in older texts as Finkelstein’s disease or Seidlmayer syndrome — is one of medicine’s most dramatic-looking but ultimately benign conditions. It is a small-vessel vasculitis affecting infants, producing spectacular purpuric and ecchymotic (bruise-like) plaques that arrive almost overnight, often sending terrified caregivers rushing to emergency departments.[1,2]

The condition was first described by Seidlmayer in 1939 and by Snow in 1913, though Finkelstein had noted similar cases even earlier in 1894. Despite a century of literature, AHEI is still frequently mistaken for more ominous diagnoses — septicaemia, Henoch–Schönlein Purpura (HSP), child abuse, or meningococcal disease — because the skin findings look so alarming.[3]

Key message: The rash of AHEI is almost always self-limiting. Most children are well within 1–3 weeks, with no organ involvement, no scarring, and no long-term sequelae. The challenge is not treatment — it is correct recognition.

Who gets it — and when

4–24
typical age range
(months)
2:1
male to female
ratio
~14 days
average time to
full resolution
< 1%
recurrence
rate

AHEI predominantly affects infants between 4 months and 2 years of age, with the highest incidence between 4 and 24 months. Cases outside this range have been reported, but they are rare. A mild male predominance (roughly 2:1) has been noted in several case series.[4]

The condition is not truly rare — it is underreported and underdiagnosed. In a retrospective review by Fiore et al. (2008), AHEI accounted for a significant proportion of leukocytoclastic vasculitis referrals in the paediatric age group when looked for specifically.[5]

Seasonal pattern: AHEI follows a striking autumn–winter peak, coinciding with the respiratory virus season. Approximately two-thirds of cases are preceded by an upper respiratory tract infection, otitis media, or urinary tract infection by 1–3 weeks.[1,3]

Common preceding events identified in the literature include:

  • Upper respiratory tract infections (most common)
  • Otitis media
  • Urinary tract infection
  • Vaccinations (MMR, DTP, meningococcal)
  • Antibiotic use (amoxicillin being most frequently implicated)
  • Insect bites (less commonly)

What is happening inside the skin

AHEI is classified as a leukocytoclastic vasculitis — a pattern of small-vessel inflammation where neutrophils infiltrate and destroy vessel walls, leaving behind debris (“nuclear dust”). The immune mechanism involves deposition of immune complexes (antigen–antibody complexes) in the walls of small dermal blood vessels, triggering complement activation and neutrophil recruitment.[6]

Immunofluorescence studies have demonstrated IgA, IgM, C3, and fibrinogen deposition in vessel walls in some cases, though IgA deposition — the hallmark of HSP — is inconsistent and when present is usually less prominent than in HSP.[3,7]

“The pathological findings in AHEI may be indistinguishable from those of Henoch–Schönlein purpura on routine histology, yet the clinical course is entirely different — strikingly self-limited and benign.” — Bolognia, Schaffer & Cerroni (2018)[6]

The absence of systemic organ involvement (kidney, gut, joints) despite florid skin vasculitis remains intriguing. Current thinking suggests that in AHEI, the immune complex insult is limited to the dermis, without the IgA-dominant, multisystem involvement that characterises HSP. The specific antigen driving immune complex formation is usually never identified, though viral antigens are presumed in most cases.

The diagnostic triad

The clinical presentation of AHEI is almost pathognomonic — once seen, it is hard to forget. The classic triad, described by Legrain et al. (1991), consists of:[8]

◈
Dramatic purpura Cockade (rosette/target) shaped ecchymotic plaques, predominantly on face, ears, and limbs
◈
Oedema Non-pitting, firm oedema of the face (especially periorbital), ears, dorsum of hands and feet
◈
Fever Low-grade fever, often present but not universal; child appears well out of proportion to severity of rash

The cockade or medallion morphology of the plaques is characteristic: purpuric patches with concentric rings of varying colour (red, purple, and brown), resembling a target or rosette. Lesions range from 1–5 cm and are most densely distributed on the face, ears (pinna involvement is classic), and lower limbs. The trunk is notably spared in most cases.[1,4]

Ear involvement: Palpable, purpuric plaques on the pinna are a particularly helpful clue. While HSP and meningococcal purpura can affect the limbs and trunk, prominent ear involvement is more typical of AHEI and should lower the threshold for this diagnosis in an otherwise well-looking infant.[2]

Mucous membranes are typically spared. The child, despite looking florid and alarming on the surface, is usually playful, feeding well, and in no systemic distress — a crucial clinical observation. This dissociation between frightening appearance and well general state is one of the most important pointers to AHEI.

Telling it apart from HSP and other mimics

The single greatest diagnostic challenge in AHEI is distinguishing it from Henoch–Schönlein Purpura (IgA vasculitis), as both cause purpuric rashes in young children following infections. The table below summarises key distinguishing features:[1,2,3,6]

Feature AHEI HSP (IgA Vasculitis)
Age4 months – 2 years3 – 10 years (peak)
Rash morphologyCockade/medallion ecchymotic plaquesPalpable purpura, petechiae
DistributionFace, ears, limbs (trunk spared)Lower limbs and buttocks (symmetric)
OedemaProminent facial/acralMild, less prominent
Arthritis/arthralgiaAbsentPresent in ~75%
Renal involvementAbsent (very rare case reports)Present in ~40–50%
GI involvementAbsentPresent in ~60%
IgA deposition (DIF)Inconsistent / absentProminent (diagnostic)
Resolution1–3 weeksWeeks to months
RecurrenceRare (<5%)Up to 33%
Do not miss: The most dangerous differential is meningococcal septicaemia. Any unwell infant with purpura, high fever, and signs of sepsis must be treated as meningococcaemia until proven otherwise. AHEI is a diagnosis of exclusion in a well-looking child. When in doubt — treat for sepsis first.

Other important differentials include:

  • Urgent Meningococcal / bacterial septicaemia — unwell child, high fever, rapidly progressive
  • Urgent Child abuse / non-accidental injury — pattern assessment, safeguarding history
  • Consider Erythema multiforme — targetoid but less haemorrhagic; mucous membrane involvement
  • Consider Urticaria multiforme — wheals, no true purpura, dermatographism
  • Less urgent Drug hypersensitivity reactions
  • Less urgent Sweet syndrome — rarer; neutrophilic, elevated inflammatory markers

How doctors confirm the diagnosis

AHEI is primarily a clinical diagnosis. In a well-appearing infant with the characteristic triad — cockade purpura on the face, ears, and limbs; facial oedema; low-grade fever — no further testing is strictly required if the child is clinically stable.[1,3]

However, in practice, investigations are often performed to exclude more serious diagnoses, especially at the first presentation. Typical findings include:

  • Full blood count: Usually normal or mild leukocytosis. Platelets normal — this is key to ruling out thrombocytopaenia-related purpura.
  • Coagulation screen: Normal PT and APTT distinguish AHEI from DIC or coagulopathy.
  • CRP / ESR: Mildly elevated or normal.
  • Renal function / urinalysis: Normal — no haematuria or proteinuria (differentiates from HSP nephritis).
  • Blood culture: Negative (performed to exclude septicaemia).
  • Serum IgA: Normal or slightly elevated; not consistently elevated as in HSP.
Skin biopsy: Not routinely required. When performed, histology shows leukocytoclastic vasculitis of small dermal vessels, with perivascular neutrophil infiltration, nuclear dust, and red blood cell extravasation. Direct immunofluorescence (DIF) shows variable, non-specific immunoglobulin deposition — IgA, when present, is usually weak and inconsistent.[6,7]

Management — less is more

This is where AHEI stands apart from most paediatric vasculitides: no specific treatment is required. The cornerstone of management is reassurance — to the family and to the clinical team.[1,2]

The following principles guide management:

  • Watchful waiting: Lesions resolve spontaneously in 1–3 weeks without treatment in the vast majority of cases.
  • Corticosteroids: Not routinely indicated. Some authors have used short courses of oral prednisolone for severe or prolonged cases, but there is no strong evidence base. Garty et al. and others have noted that steroids do not significantly alter the course.[9]
  • Antihistamines: May be used for symptomatic comfort if itching is present, though the rash is not typically pruritic.
  • Identify and treat triggers: If an underlying infection (e.g., otitis media) prompted the reaction, treat it appropriately.
  • Avoid unnecessary admissions: A well-looking child with a clear clinical picture can be managed as an outpatient with clear safety-netting advice.
Safety-netting advice for parents: Parents should be advised to return promptly if the child becomes unwell, develops high fever, stops feeding, or if new organ symptoms (joint swelling, blood in urine, vomiting, abdominal pain) emerge. These would raise the possibility of HSP or another systemic diagnosis.[2]

Hospitalisation may be appropriate for the first episode when the diagnosis is uncertain, to perform investigations and observe the child’s trajectory. Once diagnosis is confirmed and the child is shown to be systemically well, outpatient follow-up is sufficient.

Prognosis and follow-up

The prognosis of AHEI is excellent. In the landmark review by Legrain et al. (1991) and subsequent series, virtually all cases resolved without sequelae.[8] Skin lesions fade over 1–3 weeks, typically without post-inflammatory hyperpigmentation or scarring. The oedema resolves in parallel.

Recurrence is uncommon, reported in fewer than 5% of cases, usually following another triggering infection. Chronic or recurring AHEI should prompt reassessment of the diagnosis — particularly to reconsider HSP or other vasculitides.[3]

Renal involvement has been reported in isolated case reports but is sufficiently rare that routine long-term renal follow-up is not warranted unless urinalysis is abnormal at presentation.[1,5]

Parent communication tip: When speaking to worried parents, a useful analogy is: “Your baby’s immune system is fighting off a bug, and some of the fight is happening just under the skin. The skin is showing a reaction that looks alarming, but the infection itself has already been dealt with — the rash is essentially the aftermath, and it will clear completely.”

References

  1. 1Tlougan BE, Podjasek JO, O’Haver J, Cordova KB, Nguyen XH, Tee R, Hansen RC. Acute hemorrhagic edema of infancy (AHEI): a practice-based approach. Pediatric Dermatology. 2013;30(2):222–229.
  2. 2Paller AS, Mancini AJ. Hurwitz Clinical Pediatric Dermatology. 5th ed. Philadelphia: Elsevier; 2016. pp.505–506.
  3. 3Waskerwitz S, Christodoulou J. Finkelstein’s disease (acute hemorrhagic edema of infancy). In: Irvine AD, Hoeger PH, Yan AC, eds. Harper’s Textbook of Pediatric Dermatology. 3rd ed. Oxford: Wiley-Blackwell; 2011. Chapter 56.
  4. 4Kraft JN, Frieden IJ. Vascular reactions: urticaria, erythema multiforme, and drug hypersensitivity reactions. In: Eichenfield LF, Frieden IJ, Esterly NB, eds. Neonatal Dermatology. 2nd ed. Philadelphia: Saunders; 2008.
  5. 5Fiore E, Rizzi M, Ragazzi M, Vanoni F, Bernasconi M, Bianchetti MG, Simonetti GD. Acute hemorrhagic edema of young children (cockade purpura and edema): a case series and systematic review. Journal of the American Academy of Dermatology. 2008;59(4):684–695.
  6. 6Callen JP, Mancini AJ. Cutaneous vasculitis. In: Bolognia JL, Schaffer JV, Cerroni L, eds. Dermatology. 4th ed. Philadelphia: Elsevier; 2018. Chapter 24.
  7. 7Mancini AJ, Shani-Adir A. Other viral diseases. In: Bolognia JL, Schaffer JV, Cerroni L, eds. Dermatology. 4th ed. Elsevier; 2018.
  8. 8Legrain V, Lejean S, Taieb A, Guillard JM, Battin J, Maleville J. Infantile acute hemorrhagic edema of the skin: study of ten cases. Journal of the American Academy of Dermatology. 1991;24(1):17–22.
  9. 9Garty BZ, Poznanski O. Acute hemorrhagic edema of infancy. Israel Medical Association Journal. 2000;2:546–547.
  10. 10Trapani S, Mariotti P, Resti M, Nappini L, De Martino M, Falcini F. Severe hemorrhagic bullous lesions in Henoch-Schönlein purpura: three paediatric cases and review of the literature. Rheumatology International. 2010;30(8):1063–1067.
  11. 11Burns T, Breathnach S, Cox N, Griffiths C, eds. Rook’s Textbook of Dermatology. 9th ed. Oxford: Wiley-Blackwell; 2016. Chapter on vasculitis.